with 3.6 x 10 ( -6 ) , 7.2 x 10 ( -6 ) , 14.7 x 10 ( -6 ) , and 29.5 x 10 ( -6 ) mol/l lidocaine , reperfusion-induced ventricular fibrillation and tachycardia were reduced from their control incidence of 83 % and 100 % to 41 % and 58 % , 33 % ( p less than 0.05 ) and 25 % ( p less than 0.001 ) , 8 % ( p less than 0.01 ) and 8 % ( p less than 0.001 ) , 0 % ( p less than 0.001 ) and 0 % ( p less than 0.001 ) , respectively .
C0023660
lidocaine
C0042510
ventricular fibrillation